IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

Thomas A. Mace(The Ohio State University), Gregory B. Lesinski(The Ohio State University)
Gut
October 21, 2016
Cited by 540


Related Papers